News
Chemokines, our body's chemical messengers, play a crucial role in regulating the immune response. They are secreted by ...
The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...
Array Bridge is testing promising drug candidates that can effectively bind and even degrade target proteins, but not via their active sites.
What people don’t realize is that just because chemotherapy ends, fear doesn’t, and neither do the side effects from treatment.
An advantage of whole-body MRIs over CTs is that they use magnets and radio waves, which eliminate the type of radiation ...
Spending some time in the sun, getting regular exercise and eating fish may be all you need to reduce your chance of ...
Background: T-cell receptor (TCR) repertoires provide insights into tumor ... to the Lung (n = 444) and thyroid carcinoma (THCA) (n = 430) datasets. For the lung dataset, 260 samples were from healthy ...
4d
MedPage Today on MSNSniffing Out Lung Cancer: Breath Analyzer Moves Closer to Clinical UseElectronic "nose" analysis of exhaled breath achieved 80-90% accuracy for detecting lung cancer in patients with suspicious ...
Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung ...
Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...
Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...
4d
News-Medical.Net on MSNDynamic BH3 profiling offers personalized lung cancer therapiesEighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results